Carbamazepine Toxicity Masquerading as Complex Febrile Seizures in a Pediatric Patient

Richard J Chen1, Muhammad Ershad1, Maricel Dela Cruz1

  • 1Drexel University College of Medicine, Department of Emergency Medicine, Division of Medical Toxicology, Philadelphia, PA, USA.

Insights

Carbamazepine overdose can mimic seizures, leading to misdiagnosis. Prompt identification and treatment with activated charcoal resolved symptoms in a toddler, highlighting the importance of considering xenobiotic exposure.

Area of Science:

  • Pediatric Neurology
  • Clinical Toxicology

Background:

  • Carbamazepine is an antiepileptic medication.
  • Carbamazepine overdose can induce seizure-like activity.
  • Overdoses may be misdiagnosed as primary seizure disorders.

Observation:

  • A 20-month-old female presented with fever and seizure-like activity.
  • Initial diagnosis considered complex febrile seizures.
  • Elevated carbamazepine level (29 mcg/ml) was detected.

Findings:

  • Multidose activated charcoal administration led to a downtrend in carbamazepine levels.
  • The patient's condition improved significantly.
  • No permanent neurological deficits were observed upon discharge.

Implications:

  • Xenobiotic exposure, even without clear historical indicators, should be considered in differential diagnoses.
  • Early identification of drug toxicity is crucial for timely and effective treatment.
  • This case underscores the importance of toxicology screening in patients presenting with unexplained neurological symptoms.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
529
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
134
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
734